What is Sangoma Technologies Corp (SANG)'s fair-value range?

EvidInvest reads Sangoma Technologies Corp (SANG)'s market price back into the assumptions behind it — the implied P/E, growth rate and cash yield — using its latest filed financials, then lets you set your own. See the full DCF, Graham number, EPV and multiple-based methods at https://evidinvest.com/valuation/SANG.

How is Sangoma Technologies Corp (SANG)'s fair value calculated?

Sangoma Technologies Corp (SANG)'s fair value is computed with several independent methods — a discounted cash flow (DCF) model, the Graham number, earnings power value (EPV), and valuation multiples (PE, EV/EBITDA, P/S, P/B) benchmarked against its industry — using data from SEC filings.

What is Sangoma Technologies Corp (SANG)'s PE ratio versus its industry?

EvidInvest shows Sangoma Technologies Corp (SANG)'s current and historical PE ratio alongside its sector and industry averages, so you can see whether the stock trades at a premium or discount to peers. Full breakdown at https://evidinvest.com/valuation/SANG.

Fair value · Sangoma Technologies Corp (SANG) · updated 2026-09-13 · from 40-F FY2025

Sangoma Technologies trades at $3.56. That price implies 2.7× EV/EBITDA and a 24.5% free-cash-flow yield.

Cboe · delayed 15 min · as of 03:40 ET

Are those assumptions reasonable? Use SANG’s filed growth history and the AI chat to decide, then set your own inputs below — the range you build is yours.

What the price implies

EV/EBITDA: 2.7×
FCF yield: 24.5%

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings. This price: Cboe · delayed 15 min · as of 03:40 ET.

Set your own assumptions ↓See how each method got its number Check another stock

The filing behind these numbers

Sangoma Technologies Corp

Revenue: $236.7M
Diluted EPS: $-0.15
Free cash flow: $39.4M; operating cash flow − capital expenditure
Diluted shares: 33.5M; weighted average

40-F FY2025 · fiscal year ended 2025-06-30 · filed 2025-09-17 · accession 0001753368-25-000018

Open this filing on sec.gov

Valuation tool: build your own SANG range

Fair Value Summary

Daily Price — SANG

$3.73 -33.0% (1Y)

Your range0 of 7 methods

At least two methods need a usable value to draw a range with these inputs.

Range with preset inputs

No preset range for this company yet.

The two ranges are identical because every input sits on a preset.

We don’t tell you what SANG is worth. Every tab OPENS on what today’s price implies for that method’s key assumption; you decide whether that assumption is reasonable — the growth matrix has SANG’s filed history and the AI chat will reason it through with you — and the range you build is yours. Our presets are filed history and reference settings, never a recommendation.

Discounted cash flow

$19.75per share

455% above the $3.56 price· outside the ±300% band, left out of the range

Your stage-1 FCF growth (5.0%) is above the -22.1% the price implies — your value lands 455% above the price.

Preset inputs — revenue-driven DCF from the latest filing

Two-stage FCF model at the same filed inputs: $15.07 — move any slider below and that model takes over.

Implied by today’s price

At $3.56 the market implies a stage-1 FCF growth of -22.1%. (two-stage FCF model solved for stage-1 growth at 10.71% WACC)

The price implies stage-1 FCF growth of -22.1%, outside the range this slider covers. Showing preset inputs.

Implied discount rate (holding growth): 29.5% · the WACC that makes the same model print the price

That is the assumption the market is making — not ours, and not a recommendation. Decide whether it is reasonable: the growth matrix shows what SANG has actually filed, and the AI chat will reason it through with you.

Your inputs

Free cash flow grows at your stage-1 rate, then your stage-2 rate, then a terminal rate; everything is discounted at your WACC.

Stage-1 growth5.0%

Yearly free-cash-flow growth for the first stage. Starts below zero so a shrinking-cash-flow case — and the rate today’s price implies — can be set.

-20.0%60.0%

Stage-1 years5 yrs

How long stage-1 growth lasts.

1 yrs10 yrs

Stage-2 growth2.5%

Slower growth after stage 1, before the terminal phase.

-20.0%30.0%

Stage-2 years5 yrs

0 yrs10 yrs

Terminal growth2.5%

Growth forever after the two stages. Above ~3% is rarely justified.

0.0%5.0%

Discount rate (WACC)10.71%

The return you require. Default is the WACC EvidInvest computed for this company. Higher discount rate, lower value.

3.00%15.00%

Net debt ($M)Debt minus cash, from the balance sheet. Subtracted from enterprise value.

Starting FCF ($M)Latest free cash flow from the filing (operating cash flow minus capex).

Shares (M)Diluted shares, from the filing.

Year by year (two-stage model, $M)

PV explicit $286M · PV terminal $254M · EV $540M · equity $497M

Year	Stage	FCF	Present value
1	Stage 1	$41M	$37M
2	Stage 1	$43M	$35M
3	Stage 1	$45M	$33M
4	Stage 1	$47M	$32M
5	Stage 1	$50M	$30M
6	Stage 2	$51M	$28M
7	Stage 2	$52M	$26M
8	Stage 2	$54M	$24M
9	Stage 2	$55M	$22M
10	Stage 2	$56M	$20M

Inputs from the filing

Free cash flow: $39.4M; latest full year
EBIT: $-2.8M; latest annual
Shares: 33.2M
Total debt: $56.1M
Cash: $13.5M
Net debt: $42.6M; debt − cash

40-F FY2025 · period ended 2025-06-30 · filed 2025-09-17 · accession 0001753368-25-000018 · sec.gov

Prefer a blank slate with reverse DCF? Open the standalone DCF / reverse DCF for SANG

Loading history...

Sangoma Technologies trades at $3.56. That price implies 2.7× EV/EBITDA and a 24.5% free-cash-flow yield.

The filing behind these numbers

Valuation tool: build your own SANG range

Daily Price — SANG

Your range0 of 7 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on SANG

Compare with peers

Explore

Valuation tool: build your own SANG range

Daily Price — SANG

Your range0 of 7 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on SANG

Compare with peers

Explore